Keppra and Beconase aq drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Keppra (levetiracetam) and Beconase aq (beclomethasone dipropionate monohydrate). Common drug interactions include chronic kidney disease among females and aggression among males.
The phase IV clinical study analyzes what interactions people have when they take Keppra and Beconase aq. It is created by eHealthMe based on reports of 13 people who take the same drugs from the FDA, and is updated regularly.
What is Keppra?
Keppra has active ingredients of levetiracetam. It is often used in epilepsy. eHealthMe is studying from 73,504 Keppra users. Check the latest studies of Keppra.
What is Beconase aq?
Beconase aq has active ingredients of beclomethasone dipropionate monohydrate. It is often used in allergies. eHealthMe is studying from 1,293 Beconase aq users. Check the latest studies of Beconase aq.
13 people who take Keppra and Beconase aq together, and have interactions are studied.

What are the common drug interactions of Keppra and Beconase Aq, by gender? *:
female:
- Chronic kidney disease
- Renal injury (kidney injury)
- Drug ineffective
- Dyspnoea (difficult or laboured respiration)
- Fluid retention (an abnormal accumulation of fluid in the blood)
- Renal failure (kidney dysfunction)
male:
- Aggression
- Nervousness
- Agitation (state of anxiety or nervous excitement)
- Anger
- Anxiety
- Complex partial seizures (epileptic seizure)
- Confusional state
- Depression
- Dry eye (lack of adequate tears)
- Feeling of body temperature change
What are the common drug interactions of Keppra and Beconase Aq, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
- Slow speech
- Visual impairment
- Appetite disorder (abnormal eating habits)
- Hunger
- Abnormal sensation in eye
- Aggression
- Dizziness
- Hypersomnia (excessive daytime sleepiness (eds))
- Hypoglycaemia (deficiency of glucose in the bloodstream)
- Mental disorder (a psychological term for a mental or behavioural pattern or anomaly that causes distress or disability)
30-39:
- Chronic kidney disease
- Renal injury (kidney injury)
- Renal failure (kidney dysfunction)
40-49:
n/a
50-59:
n/a
60+:
n/a
What are the existing conditions these people have? *
- Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 4 people, 30.77%
- Depression: 3 people, 23.08%
- Stress And Anxiety: 2 people, 15.38%
- Seizures (abnormal excessive or synchronous neuronal activity in the brain): 2 people, 15.38%
- Multiple Allergies (allergy to multiple agents): 2 people, 15.38%
- Inflammation: 2 people, 15.38%
- Birth Control: 2 people, 15.38%
- Asthma: 2 people, 15.38%
- Skin Papilloma (a general medical term for a tumour of the skin or mucous membrane with finger-like projections): 1 person, 7.69%
- Sinus Congestion (blockage of sinus): 1 person, 7.69%
* Approximation only. Some reports may have incomplete information.
Do you take Keppra and Beconase aq?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
- Keppra (73,504 reports)
- Beconase aq (1,293 reports)
Browse all drug interactions of Keppra and Beconase aq:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Keppra:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Beconase aq:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Keppra and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Beconase aq and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zRelated publications that referenced our studies
- Schattner A, Al-Bewerat A, "Levetiracetam (Keppra), urinary retention and literature search", A fatty cause of renal failure; what is your diagnosis?, 2016 Oct .
- Spengler DC, Montouris GD, Hohler AD, "Levetiracetam as a possible contributor to acute kidney injury", Clinical therapeutics, 2014 Aug .
- Almeida DM, Jean MR, Chystsiakova A, Monahan E, Oliveira SB, Monteiro IM, "Levetiracetam-associated acute pancreatitis in an adolescent with autism: a case report", Pancreas, 2013 Jan .
- Schattner A, Al-Bewerat A, "Levetiracetam (Keppra), urinary retention and literature search", A fatty cause of renal failure; what is your diagnosis?, 2016 Oct .
- Spengler DC, Montouris GD, Hohler AD, "Levetiracetam as a possible contributor to acute kidney injury", Clinical therapeutics, 2014 Aug .
- Almeida DM, Jean MR, Chystsiakova A, Monahan E, Oliveira SB, Monteiro IM, "Levetiracetam-associated acute pancreatitis in an adolescent with autism: a case report", Pancreas, 2013 Jan .
How the study uses the data?
The study uses data from the FDA. It is based on levetiracetam and beclomethasone dipropionate monohydrate (the active ingredients of Keppra and Beconase aq, respectively), and Keppra and Beconase aq (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Kynmobi cause Vertigo Aggravated? - 3 seconds ago
- Could Effexor cause Pigmentation Disorder? - 4 seconds ago
- Could Androgel cause Fatigue? - 7 seconds ago
- Could Mometasone Furoate cause Panic Disorder? - 12 seconds ago
- Could Alendronate Sodium cause Lumbar Spinal Stenosis? - 15 seconds ago
- Could Aldactone cause Drowsiness? - 19 seconds ago
- Could Diphenhydramine Hydrochloride cause Gallbladder Disease? - 20 seconds ago
- Drug interactions of Finasteride and Ventolin Hfa - 21 seconds ago
- Psoriatic Arthropathy Aggravated and Hearing Loss - 27 seconds ago
- Nadolol vs. Isosorbide Mononitrate, side effect and effectiveness comparison - 29 seconds ago